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KEY MESSAGES
 MDT meetings coordinate the efforts of healthcare providers in cancer patient care.
 General practitioners are willing to make efforts to participate in MDT meetings in case of complex patient
situations.
 Continuity of information flow and good interprofessional relationships are facilitators for general
practitioners’ participation in MDT meetings.
ABSTRACT
Background: Cancer care has become complex, requiring healthcare professionals to collaborate
to provide high-quality care. Multidisciplinary oncological team (MDT) meetings in the hospital
have been implemented to coordinate individual cancer patients’ care. General practitioners
(GPs) are invited to join, but their participation is minimal.
Objectives: Aim of this study is to explore participating GPs’ perceptions of their current role
and to understand their preferences towards effective role execution during MDT meetings.
Methods: In May to June 2014, semi-structured interviews (n¼ 16) were conducted involving
GPs with MDT experience in Belgium. The analysis was done according to qualitative content
analysis principles.
Results: Attendance of an MDT meeting is perceived as part of the GP’s work, especially for
complex patient care situations. Interprofessional collaborative relationships and the GP’s per-
ceived benefit to the MDT meeting discussions are important motivators to participate.
Enhanced continuity of information flow and optimized organizational time management were
practical aspects triggering the GP’s intention to participate. GPs valued the communication with
the patient before and after the meeting as an integral part of the MDT dynamics.
Conclusion: GPs perceive attendance of the MDT meeting as an integral part of their job.
Suggestions are made to enhance the efficiency of the meetings.
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Introduction
Evolutions in oncology have made cancer care more
complex, resulting in the need for interprofessional
collaboration. Internationally multidisciplinary team
(MDT) meetings in oncology have been implemented
in hospitals to allow specialists from different disci-
plines addressing the corresponding care coordination
and communication challenge, including the general
practitioner (GP), to form the best possible team to
achieve optimal patient care [1,2]. The purpose of
these MDT meetings is to develop a strategic plan for
diagnosis, treatment and follow-up, and to discuss the
overall care of an individual patient. The European
Partnership Action against Cancer (EPAAC) described
MDT meetings as:
Multidisciplinary team meetings [which] are an alliance
of all medical and healthcare professionals related to a
specific tumour disease whose approach to cancer
care is guided by their willingness to agree on
evidence-based clinical decisions and to coordinate
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the delivery of care at all stages of the process,
encouraging patients in turn to take an active role in
their care [1].
The use of MDT meetings often leads to better care
[3,4]. GPs’ involvement in the meetings leads to better
communication between hospital-based specialists and
GPs, enhancing continuous care [5].
In Belgium, MDT meetings have been organized
since 2003 to facilitate the development with specialists
from different disciplines a strategic plan of diagnosis,
treatment and follow-up and to discuss the overall care
of an individual patient. These meetings are hospital
based and attended by several medical specialists, e.g.
oncologists, radiotherapists, radiologists, pathologists,
general surgeons, urologists, gynaecologists,
haematologists, pneumologists, gastroenterologists [6].
They have been identified as an essential step in the
clinical pathway of each new cancer patient and when-
ever the treatment plan diverges from guidelines. The
GP’s participation is officially established, although there
is no real task description. Participation is rewarded by
financial incentives. Nevertheless, the GP participation is
currently minimal (from 0 to 4% in 2014) [6].
The literature describes general barriers for partici-
pation for the different disciplines involved, including
workload [7], attendance problems [8,9], logistics and
organizational aspects [7,5,10], communication and
information problems [5,11]. The specific and personal
views of GPs regarding participation and role execu-
tion during these multidisciplinary meetings are, how-
ever, unclear.
This research aims to explore the GPs’ motivation
towards participating in MDT meetings by answering
the following questions:
1. How do GPs perceive their current role and expe-
riences regarding MDT meetings?
2. What are their preferences and expectations
towards effective role execution regarding MDT
meetings?
Method
A qualitative research methodology was chosen as it
aims to understand the lived experiences of people.
Semi-structured interviews are an appropriate method
to elicit participants’ personal experiences and preferen-
ces. Interviews may be preferred over focus group dis-
cussions when personal or sensitive issues are at stake.
Sample
We purposefully selected GPs who had participated in
at least one MDT meeting in the last five years to
learn about their experiences. According to the quali-
tative approach, we built a sample with maximum
diversity regarding language (Dutch and French-speak-
ing GPs); age; gender and practice organization;
regions and density of hospitals organizing MDT meet-
ings; and hospital size.
Within the areas selected, representatives of the
local GP circles and local GPs’ peer review groups
were contacted and asked if they had attended a min-
imum of one MDT meeting during the last five years
and if they were willing to be interviewed. Snowball
sampling of other GPs was done. For each of the areas
two GPs were selected leading to an initial sample of
16 GPs.
Additional sampling was scheduled after the ana-
lysis in case data saturation was not reached.
Data collection tool
The Belgian Health Care Knowledge Centre delivered
the literature-based interview guide and the Dutch
and French research teams adapted the interview
guide after discussion [6].
The main themes comprised GPs’ experience with
and their perceived role and preferences towards the
MDT meeting. Each research team performed a pilot
test of the guide in their native language by interview-
ing one participant. After this, the interview guide was
adapted and finalized for use (Appendix A).
Data collection process
FM, JB and CD conducted the interviews in May and
June 2014 at each interviewee’s practice. Informed
consent was obtained. All interviews were audio-
recorded and transcribed verbatim.
Analysis
Content analysis of the transcripts was done using
NVivo 10 software. In the first phase, a coding
scheme was built, based on the themes of the inter-
view guide and discussion of the first interviews’ ana-
lysis by both research teams. Subsequently, every
interview was coded by two researchers independ-
ently and discussed in pairs. Refining of the code-
book was done during further content analysis and
regular discussions between both research teams.
Discussions were held between researchers of both
teams to crosscheck the coding results. In the second
phase, the main findings and the meaning of the
results were discussed during meetings between the
two teams.
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Analysis of the final interviews revealed no new
themes. Therefore, we concluded that we had reached
data saturation and an additional sampling procedure
was not necessary.
Ethical approval was obtained from the Comite
d’Ethique Hospitalo-Facultaire Universitaire of Liege
and the central ethical committee of the University
Hospital Ghent (no. B670201421076).
Results
Sample description
Sixteen GPs were interviewed, of whom six were
female. Half of the participants were Dutch speaking;
half were French speaking. The mean age was 48.75
years (range: 29–67 years). Five GPs were working solo
and four in pairs. The remaining seven GPs worked in
group practices, of which three were in a mono-discip-
linary and four in a multi-disciplinary practice. Three of
the latter multi-disciplinary practices had a capitated
payment system. Sample characteristics are shown in
Table 1.
Four core themes
After analysis, four core themes emerged: (1) GPs’ per-
ceived role and input in MDT meetings; (2) GPs’ per-
ceived interactions with other MDT meeting
participants; (3) GPs’ role as communicators and exec-
utors of meeting decisions regarding the patient; and
(4) organizational issues for the participation of the GP
in MDT meetings.
(1) GPs’ perceived role and input in MDT meetings.
GPs in our study had a clear opinion about their role
in the meeting, based upon their specific position and
role in healthcare: they share a history of care with the
patient, resulting in a repertoire of knowledge
managed by the GP. This repertoire contains medical
facts (e.g. previous diseases), social facts (e.g. the
home care situation) and personal facts (e.g. a
patient’s way of coping with misfortune) that can be
brought to the MDT meeting to clarify the patient’s
situation.
Some participants, however, hesitated to bring this
latter information into the meeting that was some-
times perceived as a medical specialist meeting.
Some GPs positioned themselves as the patient’s
representative because of their access to this kind of
information.
Others felt they were appointed as the representa-
tive by the patient’s explicit demand that they partici-
pate in the MDT meeting. According to these GPs,
patients considered the GP’s participation as a reassur-
ance of good care. In these cases, the intensely per-
sonal relationship between the GP and the patient
resulted in the sense of moral responsibility for the GP
to address a specific patient request.
For most participants, complex medical situations
(e.g. multimorbidity) and complex home care situa-
tions (e.g. absence of family support) especially
prompted the GP to attend the MDT meeting and to
participate in the deliberation process. The main rea-
son was the direct impact of the MDT conclusions on
the GP’s work, such as organizing home care (in the
case of home care complexity) or acquiring new med-
ical knowledge (in the case of medical complexity).
Regarding straightforward cases, other ways of infor-
mation sharing were sought, like calling the medical
specialist. Only a minority of GPs declared that they
tried to attend even the meetings on straightforward
cases.
In early disease stages, when discussions are mostly
about curative treatments, GPs feel less competent in
playing a significant role. During the latter, advanced
Table 1. Sample characteristics.
Participant Language M/F Age Practice Payment model: capitation/fee-for-service (FFS)
GP 1 Dutch F 55 Group: mono-disciplinary FFS
GP 2 Dutch M 42 Group: multi-disciplinary FFS
GP 3 Dutch F 29 Duo FFS
GP 4 Dutch M 38 Solo FFS
GP 5 Dutch F 61 Duo FFS
GP 6 Dutch M 58 Solo FFS
GP 7 Dutch M 63 Solo FFS
GP 8 Dutch M 47 Group: mono-disciplinary FFS
GP 9 French F 56 Duo FFS
GP 10 French F 38 Solo FFS
GP 11 French M 37 Group: multi-disciplinary Capitation
GP 12 French M 39 Solo FFS
GP 13 French M 67 Group: multi-disciplinary Capitation
GP 14 French F 48 Duo FFS
GP 15 French M 62 Group: mono-disciplinary FFS
GP 16 French M 40 Group: multi-disciplinary Capitation
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palliative stages, they feel they have a more important
role.
(2) GPs’ perceived interactions with other MDT meet-
ing participants. Participating GPs felt welcome at the
MDT meeting. Most of the time, they experienced their
participation as appreciated and their contribution was
respected. The reciprocal appreciation created the feel-
ing of being part of a team, facilitating active GP
involvement. This was reported more in relation to
smaller hospitals with well-known specialists than in
large university hospitals with ever-changing team
members.
The interaction with other MDT members enhanced
the quality of the relationship itself. Personally know-
ing your interlocutor, as is the case in the smaller hos-
pitals, helps to overcome some difficulties (e.g.
interprofessional hierarchy) between GPs and special-
ists. The interaction also influenced a GP’s perception
of his tasks and role and, therefore, enhanced his
readiness towards future participation.
The opportunity and affordance of playing this role,
however, depends on task agreements between the
GP and the specialists during the meeting. These
agreements are to be negotiated for every situation
and patient individually. A major task agreement is on
communicating MDT meeting decisions to the
patient—what has to be said and by whom—to avoid
conflicting or mixed messages.
The benefit of direct discussion and reaching a
consensus during the meeting compared with the
one-way communication of referral letters equally pro-
motes GPs’ participation.
Box 1. PARTICIPANT QUOTES ON THEME 1: GPS’ PERCEIVED
ROLE AND INPUT IN MDT MEETINGS
‘There may be new elements in the meantime,
which can intervene. And, well, I realize that at
the MDT meetings they do not always have all
the longitudinal information that we have since
we have known the patients for a long time and
there’s also the non-medical part of our informa-
tion which can be interesting sometimes.’ (GP15:
M, 62.)
‘I think at that moment I can perhaps represent
the voice of the patient, like “I do want a par-
ticular treatment or not; I want to undergo
chemo or not; I have a euthanasia will, please
take this into account.” I think that is the
moment where you can make a contribution as
a GP.’ (GP1: F, 55.)
‘Patients like you being there. If they know that
you went, it gives them, well, yes, “My GP was
there also”; if you can say “We sat all together
and discussed it,” that is something … well, I
think that patients like this. It gives trust.’ (GP8:
M, 47.)
‘I will go the MDT meetings if I know that it is a
complex case. A young woman is having breast
cancer, who is having kids, and where I expect
that many things will happen and where it is
important that the communication with the spe-
cialist is fine-tuned. Yes, then I will make an extra
effort.’ (GP2: M, 42.)
‘If the decisions are purely related to their speci-
ality, I will not contribute, I let them—I mean,
that is how they prefer it. But if, for example …
like my 85-year-old patient, who already had
lymph node cancer, with metastases, the family
decided themselves: “We really aren’t doing any-
thing anymore for that, it makes no sense to do
that.” Yes, so that is the voice I represent. And
then they say: “Okay, all right.” Then they listen.
They do not say like: “We still should do this or
that.” Well, then you play an important role.’
(GP5: F, 61.)
Box 2. PARTICIPANT QUOTES ON THEME 2: GPS’ PERCEIVED
INTERACTIONS WITH OTHER MDT MEETING PARTICIPANTS
‘In the smaller hospitals, you feel more like part
of that team. That stimulates you to go. It is a
vicious circle. Because of that, they know you
better. Whereas in a big university hospital, you
do not get on board.
I: If you say: I feel more like being part of a team,
what makes you feel like that?
GP: That is in the communication sphere, eh. Part
of the information on the GP’s level is passed to
us and a division of tasks is done, like who will
do which part of the care? Whereas in the bigger
centre, everything is organized there. In fact, an
oncology patient treated in a university hospital,
doesn’t need a GP.’ (GP2: M, 42.)
‘To feel involved in the team, to meet the spe-
cialists whose signature is the only thing you
knew of—yes, it is important. And as the com-
munication goes well, afterwards to more easily
request a supplement by phone… . It is import-
ant that the specialist knows me and that I know
the specialist.’ (GP13: M, 67.)
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(3) GPs’ role as communicators and executors of
meeting decisions concerning the patient. GPs consider
the communication of meeting decisions an important
responsibility, in terms of providing answers to the
patient’s questions by bringing back new information;
enhancing treatment adherence by advocating the
chosen treatment options; and ensuring the patient’s
understanding of the disease and treatment by provid-
ing adequate explanation. This conversation is to be
seen in terms of continuity with previous conversa-
tions with the patient before the meeting. Most GPs
preferred to take up this role, positioning this in their
relationship with the patient and safeguarding the
communication continuity they have with them.
Others accepted this as a specialist role in cases where
the patient was hospitalized during the time of the
MDT meeting.
An extra motivation to attend the MDT meeting
was the GPs’ need for timely and detailed informa-
tion on the MDT conclusions to ensure adequate
and comprehensive organization of home care for
patients who were discharged from hospital, includ-
ing technical aspects of treatments (e.g. stoma care),
practical aspects to respond to patient disabilities
(e.g. home care nurses) and treatment side effects
which can be prevented or better managed if
known about beforehand. In their opinion, the
written meeting report does not sufficiently
provide the necessary information required to organ-
ize good care.
(4) Organizational issues for the participation of the
GP in MDT meeting. Participants differed in their prefer-
ences as to how the invitation should be delivered to
the GP (by email or by telephone), but there was a
consensus that it needed to be timely. For most GPs,
this was for the practice to be organized; for others, it
would offer the opportunity to prepare for the meet-
ing and even to talk with the patient beforehand and
clarify the patient’s view.
During the meeting, the patient’s case is in general
presented by the specialist in charge of the patient.
Thereafter others, including the GP, bring in additional
information to deliberate on treatment plans. As time
management is very important for GPs, efficient organ-
ization of the MDT meeting is fundamental to them:
making sure that the necessary specialists are present,
giving priority to patients of participating GPs and
structuring the discussion.
MDT meetings through video conferencing were
positively evaluated. Two participants had experience
of it, although the majority of MDT meetings are cur-
rently co-located. The most positive attribute of video
meeting is its limited impact on practice organization
and time loss. Those participants who had experience
of using video meetings expressed a preference
towards expanding their use. However, other partici-
pants who had no experience of video meetings were
less in favour, fearing the loss of direct interprofes-
sional contact in this way. The direct personal contact
had previously been mentioned as a strong benefit of
co-located MDT meetings. To the GPs, it is not clear if
this loss is being outweighed by the practical benefits
of video MDT meetings.
‘And they say: “These are the results of the path-
ologist. That is the cancer type. We have these
treatment options.” Then he said: “It is for this
old person—as you see, more than 80, but a
very spirited woman. We want to give her a
chance. We go for maximum treatment. Do you
agree?” I did agree, for I had discussed it with
the family in advance. I say: “Yes, okay, every-
body is on the same wavelength, so we go for
it.” Then the treatment started, relatively soon.
That is the advantage: everybody is there at that
moment. The radiotherapist can say: “Okay, I will
pick up the patient, I will call the patient, I will
tell you when it is going to happen.” And he tells
me when it will happen. Then I can communicate
with the family. You see, these agreements are
all made within ten minutes. Do you not think
this is formidable? Otherwise, it takes days, some-
times weeks.’ (GP6: M, 58.)
Box 3. PARTICIPANT QUOTES ON THEME 3: GPS’ ROLE AS
COMMUNICATORS AND EXECUTORS OF MEETING
DECISIONS CONCERNING THE PATIENT
‘First of all, an intermediary of information and,
accordingly, support with regard to the decisions
they will take and so better understanding and
compliance by the patient. That is how I see it—
being the intermediary really to have better
compliance.’ (GP9: F, 56.)
‘I am better informed. … Even if you receive a
letter … well, still I think that there you get
some more… your patient’s follow-up is better
and afterwards you respond better if you partici-
pate. Especially with regard to the practicalities,
the diagnosis, the planning.’ (GP7: M, 63.)
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Discussion
Main findings
The main findings are:
1. Attending an MDT meeting is perceived as part of
the GP’s work, especially for complex situations.
2. Continuity of care should be the focus of
collaboration.
3. Interprofessional collaborative relationships and
the GP’s perceived benefit to the MDT meeting
are important motivators to participate.
Strengths and limitations
This is the first time that GPs’ preferences and experi-
ences regarding MDT meetings in oncology have been
described in the Belgian healthcare system. We cannot
exclude social desirability in some answers, as the
peers interviewed the participants. Our study is based
on the views of GPs on the MDT meeting experience
although as a recent survey has shown [6], only a
minority of GPs is attending (about four per cent of all
MDT meetings). Therefore, our results are not general-
izable to the whole group of GPs. A separate interview
study investigating the views of GPs without MDT
meeting experience might complement this study.
Interpretation of the results in relation to existing
literature
Although this study has been conducted in one coun-
try, the results point to several non-contextual varia-
bles affecting the process and outcome of MDT
meetings. As such, this study can be of interest
internationally, as becomes clear through the compari-
son with existing literature calling for clarity on GPs’
role in cancer care [12–14].
MDT meeting attendance is part of the GP’s job
Participants regarded attending MDT meetings as part
of their work, though the degree of complexity needs
to be high enough to be motivated to attend the
MDT meeting. Case complexity can present itself in
several ways: high technicity or complex chemother-
apy regimens, or complex psychosocial factors and
home care organization [15]. Each case has to be eval-
uated individually.
Continuity of care as part of the GP’s mission
Literature stresses that physicians accept responsibility
for continuity of care [16]. Participants in our study
also mentioned continuity as an argument for attend-
ing MDT meetings. This relates to a definition of con-
tinuity of care given by Haggerty and colleagues:
‘Continuity is the degree to which a series of discrete
healthcare events is experienced as coherent and con-
sistent with the patient's medical needs and personal
context’ [17].
Care continuity is regarded as being one of the GP’s
main foci, as described by the World Organization of
Family Doctors (Wonca). Wonca suggests six compe-
tence areas as being fundamental in the delivery of
high-quality primary care: (1) holistic modelling; (2) per-
son-centred care; (3) primary care management; (4) a
comprehensive approach; (5) specific problem-solving
skills; and (6) community orientation. All of these were
mentioned by the participants in our study as contribu-
ting in their motivation to attend the MDT meetings.
Therefore, we can state that attending MDT meetings
harmonizes with the GPs’ general mission in healthcare.
Information flow during the care continuum
A major topic of concern within the care continuum is
the information continuum. The patient’s history must
inform the MDT meeting discussion, which in turn
must shape the organization of future care. The opti-
mization of this information flow involves multiple lev-
els: preparedness to share information, organizational
aspects of the meeting providing time and space, and
the practical requirements for managing all the infor-
mation in an accessible way, e.g. a shared online
Electronic Health Record [18]. Embedded in the GP-
patient relationship, some state a preference for com-
municating the MDT meeting results to the patient
Box 4. PARTICIPANT QUOTES ON THEME 4:
ORGANIZATIONAL ISSUES FOR THE PARTICIPATION OF THE
GP IN MDT MEETING
‘Ah, we have a video MDT meeting there. This is
going brilliantly. It works perfectly. There is
always somebody at the practice who can log in.
We are notified two days before… You get an
hour to log in and it takes a maximum of ten
minutes. You do not lose time; we are at the
practice anyway. Alternatively, if you come back
and you are a little bit too early, you can read
some mail, you can do something else: fill in a
file. You can meanwhile watch your file, and
complete it. You also meet your colleagues. I
think it is brilliant.’ (GP1: F, 55.)
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instead of having them delivered by the specialist.
Patients want their GP to be more involved in their
cancer care, although both share a concern towards
acquiring and maintaining the necessary skills, includ-
ing communication skills [19].
Other studies confirm the task of a GP during can-
cer follow-up as being a flexible mediator (between
patient and clinic, interpreting and translating), an effi-
cient handyman (solving practical problems) and a
personal companion throughout the illness [20].
This positions the GP as a guardian of the informa-
tion on patients’ needs and context at the centre of
the MDT dynamics.
Case complexity
Our study shows that the GP’s role of information man-
ager is especially relevant in complex cases. In less
complex cases, a distinct way of sharing information
could be preferred [8]. Healthcare professionals such as
specialized nurses in oncology or MDT meeting organ-
izers could call the GP before the meeting with specific
questions. These questions may relate to the patient’s
preferences or to specific aspects of home care, so that
the GP can fulfil his/her role without being present.
This is a timesaving procedure for all physicians
involved. However, the benefit of a group discussion
with other disciplines is lost in this way [21]. There are,
however, differing views towards the benefit of meet-
ing each other in person, ranging from preferring to
participate in person, through video meeting, to prefer-
ence for a private telephone call to the specialist.
Exploring possible strategies for selecting appropriate
patient cases for in-person MDT meetings might benefit
the tight schedule and speedy meetings.
Positive interactions during the meetings are based
on good interprofessional relationships, enhancing
GPs’ efforts to attend. It might be helpful—e.g. by
organizing joint CME sessions—to foster interprofes-
sional relationships. Literature shows that interprofes-
sional education leads to better interprofessional
collaboration, which in turn leads to better patient
care [22,23].
Barriers for attending MDT meetings
Even though our participants regarded attending MDT
meetings as part of their work, in reality the number of
attending GPs is very low and in strong contrast with
this view. The described barriers are mostly practical or
logistical in nature, which can be overcome by video
conferencing [13]. Our study suggests that a timely invi-
tation, offering the GP enough time and opportunity to
contact the patient and discuss his/her will and treat-
ment preferences before the MDT meeting, might
reinforce GPs’ participation and might benefit the qual-
ity of GPs’ input. However, some cases require urgent
meeting scheduling, hindering timely invitation result-
ing in GPs' being absent or attending the meeting in an
unprepared way. Addressing these practical issues
shows the organizers’ knowledge and respect for the
GPs’ situation and leads to more efficient collaboration
[24]. None of the GP variables used during the sampling
procedure had a clear effect on the MDT attendance.
Small hospitals seem to attract GP involvement in MDT
meetings more than large university hospitals, as GPs
experience a lower threshold to engage in the interpro-
fessional network from the former.
GPs’ self-perceived benefit to the MDT meetings
GPs’ self-confidence about their contribution to the
MDT meeting process varies. MDT meetings are often
perceived as being focused on medical expertise. Some
participants found it difficult to bring non-medical
information into the discussion, thereby confirming the
literature [25]. This might be even more difficult if the
GP is not sure whether he/she represents the patient’s
view, due to lack of a written statement from the
patient (e.g. Advance Care Planning documents).
In the complex situation of cancer care, the collab-
oration between GPs and specialists is a necessity. GPs
spontaneously respond to this need by directly con-
tacting the oncologist and using networks of trusted
providers [14]. In our study, those informal contacts
remain important and are complementary to the MDT.
Building those professional networks is even stated as
an explicit outcome of the meetings.
Implications for research and/or practice
The synergy and complementarity between GPs and
specialists have to be highlighted. The MDT meeting’s
organizer, specialists and GPs need to be informed
and convinced of the benefit of sharing expertise. The
meeting process would benefit from a clarification of
each participant’s role [14,15].
Some important patient information (functional sta-
tus, patient’s wishes) necessary for the organization of
home care could be systematically integrated into the
MDT meeting discussion and into the meeting report.
GPs suggest a more detailed report, including specific
information relating to their role: information for the
patient (what has to be said and by whom) and infor-
mation for the organization of care at home (what is
needed and what can be expected). Other studies have
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emphasized the importance of good communication
and claim that the report needs a good structure
[21,26,27]. In the MDT meeting process, as in general,
there is an opportunity for GPs and specialists to reach
an agreement on what a report should include [28].
Standardizing the MDT meeting report with the aid of a
shared electronic patient health record might optimize
the efficiency of the information flow.
Some advantages have been mentioned about
video meeting: more GPs would prefer video meetings
due to the lack of interference with practice organiza-
tion. A prerequisite for the effective implementation of
a video meeting is the use of a uniform and simple
software package.
An MDT meeting is an operationalization of a good
concept: interprofessional patient care. Embedding the
MDT meeting in the interprofessional oncological care
continuum might raise the awareness and commitment
of all participants to enhance the effectiveness of the
entire care process. This striving towards high quality
seamless palliative care fits into the currently develop-
ing models of integrated care. This is a focus of models
of integrated care and should be further evaluated [29].
Conclusions
General practitioners perceive attendance of MDT
meetings as an integral part of their job. Case com-
plexity and good interprofessional relationships are
strong facilitators for GPs’ attendance. Ensuring a
smooth information flow and addressing practical bar-
riers for attendance—e.g. by installing video conferen-
ces—were mentioned as areas for improvement.
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Topic Content Question
The MDT meeting in theory What does the concept ‘MDT meeting’
mean?
If I say ‘MDT meeting,’ what do you think of?
How would you define an MDT meeting?
Experience What is your experience of MDT meet-
ings?
How do the meetings work out?
What is the continuation of the MDT
meeting?
How frequently do you participate in MDT meetings?
Do you have in your region experiences with MDT meetings in multiple hospitals?
If we look back at the last MDT meeting you attended, can you tell me how you
experienced this? (How were you invited? How much time before the meeting?
Which type of patient, type of tumour? What was the reason you attended? Is
this experience representative of the experiences you have had with MDT meet-
ings in general?)
How do you attend the MDT meeting? (Being present, attending through teleconfer-
ence or video conferencing?)
If you attend MDT meetings in multiple hospitals, what are the main differences?
Do your patients know in advance that an MDT meeting is organized? If so, how
and by whom are they informed (If not, why not?)
How do you experience the process of decision making during the MDT meeting? Is
deliberation happening? With whom? Who is mainly speaking? Who is taking the
final decision? What is your input during the MDT meeting?
Which information do you receive after the MDT meeting?
If you are not able to attend, how is the exchange of information about the patient
done? Do you get informed about the decisions taken? How? How do you
experience this?
Does the patient get informed? How? How do you experience this?
How is your attendance at the MDT meetings remunerated?
Perceptions GP’s role during the MDT meeting.
Positive contribution of the MDT meeting
towards the patient.
Positive contribution of the MDT meeting
towards the GP.
What do you think other participants’ expectations of your attendance at the MDT
meetings are?
What is your contribution during the MDT meeting in general?
Can the MDT meeting positively contribute to the course of the disease or treat-
ment of the patient?
Do you consider the MDT meeting as useful for every patient? Why (not)?
Does attending the MDT meeting contribute something towards you? What?
Facilitators and barriers GPs’ experiences of facilitators and bar-
riers towards attending the MDT
meetings (practical and organizational
factors, factors concerning content
and relationship).
What is your most important argument for attending the MDT meeting (or not)?
What is facilitating or interfering with your attendance of the MDT meeting?
Suggestions for improvement How could GPs’ participation at the MDT
meeting be improved?
What can be a way to improve GPs’ attendance of the MDT meeting?
Appendix A. Interview guide.
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